PharmaCyte Biotech (PMCB) Receives Nasdaq Non-Compliance Notice for Minimum $1.00 Bid Price 08 Dec 2025 SEC Filing 8-K $PMCB PharmaCyte Biotech (PMCB) Receives Nasdaq Non-Compliance Notice for Minimum $1.00 Bid Price PharmaCyte Biotech (PMCB) received a Nasdaq non-compliance notice for failing to meet the minimum $1.00 bid price requirement.
Stoke Therapeutics (STOK) CEO Sells 10,000 Shares Under Pre-Arranged Plan 07 Dec 2025 SEC Filing 4 $STOK Stoke Therapeutics (STOK) CEO Sells 10,000 Shares Under Pre-Arranged Plan Stoke Therapeutics CEO Edward M. Kaye sold 10,000 shares for $150,000 total, according to an SEC Form 4 filing.
06 Dec 2025 SEC Filing 424B5 Financing $MRK Pending Review AI-Generated Merck & Co., Inc. (MRK) Files 424B5: Offering $8 Billion in Notes Merck & Co., Inc. (MRK) filed a 424B5 prospectus supplement for an $8 billion debt offering, with proceeds potentially funding the acquisition of Cidara Therapeutics.
06 Dec 2025 News Coming soon This is Pharma8k's, a brand new site by boogy boogy that's just getting started. Things will be up and running here